A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Emory University
Emory University
National Cancer Institute (NCI)